Efficacy of NT 201 (Xeomin®; Botulinum neurotoxin type A free from complexing proteins) in the treatment of patients with focal dystonia

被引：0
|
作者：
Grafe, S.
Hanschmann, A.
机构：
来源：
JOURNAL OF NEURAL TRANSMISSION | 2010年 / 117卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1235 / 1235
页数：1
相关论文
共 50 条
  • [31] FLEXIBLE DOSING WITH INCOBOTULINUMTOXIN-A (XEOMIN®; BOTULINUM NEUROTOXIN TYPE-A, FREE FROM ACCESSORY PROTEINS) IN CERVICAL DYSTONIA
    Evidente, V. G. H.
    Fernandez, H. H.
    LeDoux, M. S.
    Brashear, A.
    Marx, M. W.
    Grafe, S. K.
    Comella, C. L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 511 - 511
  • [32] Efficacy and safety of a new botulinum toxin type A free of complexing proteins in treatment of cervical dystonia
    Benecke, R
    [J]. MOVEMENT DISORDERS, 2004, 19 : S110 - S111
  • [33] Xeomin® is stable without refrigeration:: Complexing proteins are not required for stability of botulinum neurotoxin type A preparations
    Grein, Swen
    Mander, Gerd J.
    Taylor, Harold V.
    [J]. TOXICON, 2008, 51 : 13 - 13
  • [34] Efficacy and Safety of Repeated NT 201 (Botulinum Neurotoxin Type A Free from Complexing Proteins) Treatments for up to 89 Weeks in Upper Limb Post-Stroke Spasticity
    Kanovsky, Petr
    Pulte, Irena
    Comes, Georg
    Grafe, Susanne
    [J]. NEUROLOGY, 2010, 74 (09) : A153 - A154
  • [35] A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia
    Benecke, R
    Jost, WH
    Kanovsky, P
    Ruzicka, E
    Comes, G
    Grafe, S
    [J]. NEUROLOGY, 2005, 64 (11) : 1949 - 1951
  • [36] Efficacy and tolerability of a botulinum toxin type A free of complexing proteins (NT 201) compared with commercially available botulinum toxin type A (BOTOX®) in healthy volunteers
    Jost, WH
    Kohl, A
    Brinkmann, S
    Comes, G
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2005, 112 (07) : 905 - 913
  • [37] Efficacy and tolerability of a botulinum toxin type A free of complexing proteins (NT 201) compared with commercially available botulinum toxin type A (BOTOX°) in healthy volunteers
    W. H. Jost
    A. Kohl
    S. Brinkmann
    G. Comes
    [J]. Journal of Neural Transmission, 2005, 112 : 905 - 913
  • [38] Safety, efficacy, and duration of effect of a new Botulinum Neurotoxin Type A preparation free of complexing proteins
    Wohlfarth, K
    Mueller, C
    [J]. MOVEMENT DISORDERS, 2005, 20 : S11 - S11
  • [39] Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke
    Santamato, Andrea
    Panza, Francesco
    Ranieri, Maurizio
    Frisardi, Vincenza
    Micello, Maria Francesca
    Filoni, Serena
    Fortunato, Francesca
    Intiso, Domenico
    Basciani, Mario
    Logroscino, Giancarlo
    Fiore, Pietro
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2013, 120 (03) : 469 - 476
  • [40] Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke
    Andrea Santamato
    Francesco Panza
    Maurizio Ranieri
    Vincenza Frisardi
    Maria Francesca Micello
    Serena Filoni
    Francesca Fortunato
    Domenico Intiso
    Mario Basciani
    Giancarlo Logroscino
    Pietro Fiore
    [J]. Journal of Neural Transmission, 2013, 120 : 469 - 476
12345